Pharmacologic Management of Overactive Bladder: Practical Options for the Primary Care Physician
Authors:
- David R. StaskinDSDavid R. Staskin
- Scott A. MacDiarmidSMScott A. MacDiarmid
- 1 March 2006
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 119 (3) , 24-28
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Management of Urinary Incontinence in WomenJAMA, 2004
- Antimuscarinics for treatment of overactive bladderThe Lancet Neurology, 2004
- Oxybutynin Extended-ReleaseDrugs, 2004
- Estimated economic costs of overactive bladder in the United StatesUrology, 2003
- Prevalence and burden of overactive bladder in the United StatesWorld Journal of Urology, 2003
- The newer antimuscarinic drugs: bladder control with less dry mouth.Cleveland Clinic Journal of Medicine, 2002
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002
- How widespread are the symptoms of an overactive bladder and how are they managed? A population‐based prevalence studyBJU International, 2001
- Prospective Randomized Controlled Trial of Extended-Release Oxybutynin Chloride and Tolterodine Tartrate in the Treatment of Overactive Bladder: Results of the OBJECT StudyMayo Clinic Proceedings, 2001
- Barriers to help seeking in people with urinary symptomsFamily Practice, 2001